Pilot Polymer Technologies

Pilot Polymer Technologies was a specialty biomaterials company that developed a proprietary platform of degradable, functionalized polymers for the life sciences industry. The company's core technology centered on amino acid-based poly(ester urea)s (PEUs), which offered tunable mechanical properties and degradation rates for medical applications. These polymers were designed for use in 3D printing of medical implants, tissue engineering scaffolds, and sophisticated drug delivery systems. Following its acquisition by Polysciences in 2018, the technology was integrated into a broader portfolio of high-performance materials for the healthcare and pharmaceutical sectors.